Angewandte Chemie International Edition
10.1002/anie.201814475
COMMUNICATION
Scheme 1. Derivatization of Arylation Products.a
98–122. (b) F.-X. Felpin, J. Lebreton, Eur. J. Org. Chem. 2003, 19,
3
693–3712.
O
[
2]
For recent reviews on the synthesis of pyrrolidinone containing
alkaloids: (a) Y. Long-Wu; C. Shu, F. Gagosz, Org. Biomol. Chem.
2014, 12, 1833–1845. (b) F. Rivas, T. Ling, Org. Prep. Proced. Int.
Ph
PMP
N
O
4
Me
a
Ph
Me
HN
3aa
2016, 48, 254−295.
b
[3]
For some examples of biologically active pyrrolidines, see: (a) A. P.
Guzikowski, A. P. Tamiz, M. Acosta-Burruel, S. Hong- Bae, S. X. Cai, J.
E. Hawkinson, J. F. W. Keana, S. R. Kesten, C. T. Shipp, M. Tran, E. R.
Whittemore, R. M. Woodward, J. L. Wright, Z. L. Zhou, J. Med. Chem.
2000, 43, 984–994. (b) C. L. Lynch, J. J. Hale, R. J. Budhu, A. L.
Gentry, S. G. Mills, K.T. Chapman, M. MacCoss, L. Malkowitz, M. S.
Springer, S. L. Gould, J. A. DeMartino, S. J. Siciliano, M. A. Cascieri, A.
Carella, G. Carver, K. Holmes, W. A. Schleif, R. Danzeisen, D. Hazuda,
J. Kessler, J. Lineberger, M. Miller, E. A. Emini, Bioorg. Med. Chem.
Lett. 2002, 12, 3001–3004. (c) M. E. Hensler, G. Bernstein, V. Nizet, A.
Nefzi, Bioorg. Med. Chem. Lett. 2006, 16, 5073–5079. (d) X. Li, J. Li,
Mini-Rev. Med. Chem. 2010, 10, 794–805. (e) K. W. Lexa, H. A.
Carlson, Proteins 2011, 79, 2282–2290. (f) L. R. Whitby, Y. Ando, V.
Setola, P. K. Vogt, B. L. Roth, D. L. Boger, J. Am. Chem. Soc. 2011,
c
CN
Ph
Me
Ph
Me
PMP
PMP
N
N
6
5
[
°
°
a] Conditions: (a) CAN, MeCN/H
C to 23 °C, 16 h, 93% yield; (c) LiBEt
C, 5 h, 43% yield, 93:7 dr.
2
O, 0 °C, 30 min, 73% yield; (b) LAH, Et
2
O, 0
3
H, –78 °C to 23 °C, then AcOH, KCN, 0
In conclusion, we have developed a protocol for the first
transition metal-catalyzed enantioselective -arylation of -
lactams. Two related procedures were developed for this
transformation, allowing for the use of either aryl chlorides or
133, 10184–10194. (g) A. Raghuraman, E. Ko, L. M. Perez, T. R.
i
Ioerger, K. Burgess, J. Am. Chem. Soc. 201 1, 133, 12350–12353. For
select examples of biologically active pyrrolidinones see: (a) J. Caruano,
G.G. Muccioli, R. Robiette, Org. Biomol. Chem., 2016, 14, 10134–
10156. (b) J. J. –W. Duan, L. Chen, Z. R. Wasserman, Z. Lu, R. –Q. Liu,
M. B. Covington, M. Qian, K. D. Hardman, R. L. Magolda, R. C. Newton,
D. D. Christ, R. R. Wexler, C. P. Decicco, J. Med. Chem. 2002, 45,
bromides as electrophiles.
We are able to construct -
quaternary stereocenters in good yield and high enantiomeric
excess (up to 91% yield and 97% ee). Asymmetry is induced
through the use of a chiral, dialkyl bisphosphine ligand that
generates a Pd/ligand complex that is stable under strongly
basic conditions and elevated temperatures. Critical to the
development of these conditions was also the identification of an
appropriate base and electrophile combination. We found that a
broad range of substitution is tolerated on either coupling
partner. We also demonstrated that these -quaternary lactams
4954–4957.
[
4]
M. Teodorescu, M. Bercea, Polym Plast Technol Eng. 2015, 54, 923–
943.
[5]
(a) P. I. Dalko, L. Moisan, Angew. Chem. 2001, 113, 3840–3864.
Angew. Chem. Int. Ed. 2001, 40, 3726–3748. b) P. I. Dalko, L. Moisan,
Angew. Chem. 2004, 116, 5248–5286. Angew. Chem. Int. Ed. 2004, 43,
5138–5175. c) B. List, Synlett 2001, 11, 1675–1686. d) B. List,
can be efficiently converted to
a
number of different
Tetrahedron 2002, 58, 5573–5590. e) B. List, Acc. Chem. Res. 2004,
37, 548–557. f) W. Notz, F. Tanaka, C. F. Barbas III, Acc. Chem. Res.
2004, 37, 580–591. (g) S. Zhang, W. Wang, Q.–L. Zhou, Privileged
Chiral Ligands and Catalysts; Ed.; Wiley-VCH: Weinheim, Germany,
enantioenriched nitrogen containing heterocyclic building blocks
via product derivatizations. Finally, we were pleased to find that
in preliminary studies our conditions can be applied to the
enantioselective -vinylation of lactams.[20] A more extensive
report of these investigations will be disclosed in due course.
2011; pp 409−439. (h) A. J. B. Watson, D. W. C. MacMillan, I. Ojima,
Enantioselective Organocatalysis Involving Iminium, Enamine SOMO
and Photoredox Activation. In Catalytic Asymmetric Synthesis, 3rd ed.;
Ed.; Wiley & Sons: Hoboken, NJ, 2010; pp 39−57. (i) C. A. Caputo, N.
D. Jones, Dalton Trans. 2007, 4627.
[
[
6]
7]
D. C. Behenna, Y. Liu, T. Yurino, J. Kim, D. E. White, S. C. Virgil, B. M.
Stoltz, Nat. Chem. 2012, 4, 130–133.
M. Hayashi, S. Bachman, S. Hashimoto, C. C. Eichman, B. M. Stoltz, J.
Am. Chem. Soc. 2016, 138, 8997–9000
Acknowledgements
[
8]
9]
L.–N. Wang, Q. Cui, Z.–X. Yu, J. Org. Chem. 2016, 81, 10165–10171.
(a) J. D. Stewart, S. C. Fields, K. S. Kochhar, H. W. Pinnick, J. Org.
Chem. 1987, 52, 2110–2113. (b) K. H. Shaughnessy, B. C. Hamann, J.
F. Hartwig, J. Org. Chem. 1998, 63, 6546–6553.
[
The NIH-NIGMS (R01GM080269) and Caltech are thanked for
support of our research program. C. I. Jette thanks the National
Science Foundation for
a
predoctoral fellowship.
I. Geibel
acknowledges the Deutsche Forschungsgemeinschaft (DFG) for a
postdoctoral fellowship (GE 3082/1-1). H.S. thanks Shionogi & Co.,
Ltd. for a research grant and fellowship. J. B. Morgan acknowledges
the University of North Carolina Wilmington for research
reassignment and travel funds. Dr. Scott Virgil (Caltech) is thanked
for instrumentation and SFC assistance.
[10] In the presence of strong base and no transition-metal catalyst, the
product was formed in good yield at 23 °C:
[
11] (a) M. J. Durbin, M. C. Willis, Org. Lett., 2008, 10, 1413–1415. (b) R. A.
Altman, A. M. Hyde, X. Huang, S. L. Buchwald, J. Am. Chem. Soc.
2008, 130, 9613–9620. (c) C.–K. Mai, M. F. Sammons, T. Sammakia,
Keywords: Palladium • -arylation • Nitrogen heterocycles •
quaternary stereocenters • asymmetric catalysis
Org. Lett. 2010, 12, 2306–2309. (d) E. Koch, R. Takise, A. Studer, J.
Yamaguchi, K. Itami, Chem. Commun. 2015, 51, 855–857. (e) J. Duan,
F. Y. A Kwong, J. Org. Chem. 2017, 82, 6468–6473. (f) P. K. R.
Panyam, B. Ugale, T. Gandhi, J. Org. Chem. 2018, 83, 7622–7632. (g)
A. Vignesh, W. Kaminsky, N. Dharmaraj, Chem. Cat. Chem. 2017, 9,
[
1]
For pyrrolidine-containing alkaloids, see: (a) T. J. Donohoe, C. J. R.
Bataille, G. W. Churchill, Annu. Rep. Prog. Chem., Sect. B 2006, 102,
910–914. (h) P. Li, S. L. Buchwald, Angew. Chem. 2011, 123, 6520–
524. Angew. Chem. Int. Ed. 2011, 50, 6396–6400. For
6
This article is protected by copyright. All rights reserved.